Silent, but not innocent: the emerging role of clonal hematopoiesis in predicting therapy-related myeloid neoplasms
Therapy-related myeloid neoplasms (t-MNs), which develop following cytotoxic chemotherapy or radiotherapy, remain one of the most significant clinical challenges in modern hematology due to their aggressive clinical course and poor survival outcomes. The traditional paradigm regarded the development of t-MNs as a conse...